227 related articles for article (PubMed ID: 25999678)
1. Optical coherence tomography enables imaging of tumor initiation in the TAg-RB mouse model of retinoblastoma.
Wenzel AA; O'Hare MN; Shadmand M; Corson TW
Mol Vis; 2015; 21():515-22. PubMed ID: 25999678
[TBL] [Abstract][Full Text] [Related]
2. The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.
Pajovic S; Corson TW; Spencer C; Dimaras H; Orlic-Milacic M; Marchong MN; To KH; Thériault B; Auspitz M; Gallie BL
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7618-24. PubMed ID: 21862643
[TBL] [Abstract][Full Text] [Related]
3. Kif14 overexpression accelerates murine retinoblastoma development.
O'Hare M; Shadmand M; Sulaiman RS; Sishtla K; Sakisaka T; Corson TW
Int J Cancer; 2016 Oct; 139(8):1752-8. PubMed ID: 27270502
[TBL] [Abstract][Full Text] [Related]
4. In vivo three-dimensional high-resolution imaging of rodent retina with spectral-domain optical coherence tomography.
Ruggeri M; Wehbe H; Jiao S; Gregori G; Jockovich ME; Hackam A; Duan Y; Puliafito CA
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1808-14. PubMed ID: 17389515
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of tumor size in a murine model of retinoblastoma.
Dimaras H; Marchong MN; Gallie BL
Ophthalmic Genet; 2009 Jun; 30(2):84-90. PubMed ID: 19373679
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a novel retinoblastoma (Rb) nude mouse model by intravitreal injection of human Rb Y79 cells - comparison of in vivo analysis versus histological follow up.
Tschulakow AV; Schraermeyer U; Rodemann HP; Julien-Schraermeyer S
Biol Open; 2016 Nov; 5(11):1625-1630. PubMed ID: 27694105
[TBL] [Abstract][Full Text] [Related]
7. Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model.
Allaman-Pillet N; Oberson A; Schorderet DF
Oncotarget; 2017 Feb; 8(9):15490-15506. PubMed ID: 28099942
[TBL] [Abstract][Full Text] [Related]
8. Multiple genetic loci modify risk for retinoblastoma in transgenic mice.
Griep AE; Krawcek J; Lee D; Liem A; Albert DM; Carabeo R; Drinkwater N; McCall M; Sattler C; Lasudry JG; Lambert PF
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2723-32. PubMed ID: 9856783
[TBL] [Abstract][Full Text] [Related]
9. HAND-HELD OPTICAL COHERENCE TOMOGRAPHY MONITORING OF CHEMORESISTANT RETINOBLASTOMA.
Malik K; Welch RJ; Shields CL
Retin Cases Brief Rep; 2020; 14(4):368-371. PubMed ID: 29443806
[TBL] [Abstract][Full Text] [Related]
10. Looking for the Most Suitable Orthotopic Retinoblastoma Mouse Model in Order to Characterize the Tumoral Development.
Lemaitre S; Poyer F; Marco S; Fréneaux P; Doz F; Aerts I; Desjardins L; Cassoux N; Thomas CD
Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3055-3064. PubMed ID: 28622397
[TBL] [Abstract][Full Text] [Related]
11. Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastoma.
Landreville S; Ma D; Wu J; Harbour JW
Curr Eye Res; 2010 May; 35(5):435-9. PubMed ID: 20450257
[TBL] [Abstract][Full Text] [Related]
12. Retinal tumor imaging and volume quantification in mouse model using spectral-domain optical coherence tomography.
Ruggeri M; Tsechpenakis G; Jiao S; Jockovich ME; Cebulla C; Hernandez E; Murray TG; Puliafito CA
Opt Express; 2009 Mar; 17(5):4074-83. PubMed ID: 19259247
[TBL] [Abstract][Full Text] [Related]
13. The RB protein family in retinal development and retinoblastoma: new insights from new mouse models.
Bremner R; Chen D; Pacal M; Livne-Bar I; Agochiya M
Dev Neurosci; 2004; 26(5-6):417-34. PubMed ID: 15855771
[TBL] [Abstract][Full Text] [Related]
14. Swept-source optical coherence tomography features of regressed macular retinoblastoma.
Damodaran S; Bajaj MS; Sharma P; Kumar A; Chawla R; Pujari A; Garg G; Temkar S
Indian J Ophthalmol; 2019 Dec; 67(12):2013-2018. PubMed ID: 31755441
[TBL] [Abstract][Full Text] [Related]
15. p107 is a suppressor of retinoblastoma development in pRb-deficient mice.
Robanus-Maandag E; Dekker M; van der Valk M; Carrozza ML; Jeanny JC; Dannenberg JH; Berns A; te Riele H
Genes Dev; 1998 Jun; 12(11):1599-609. PubMed ID: 9620848
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography.
Fischer MD; Huber G; Beck SC; Tanimoto N; Muehlfriedel R; Fahl E; Grimm C; Wenzel A; Remé CE; van de Pavert SA; Wijnholds J; Pacal M; Bremner R; Seeliger MW
PLoS One; 2009 Oct; 4(10):e7507. PubMed ID: 19838301
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel in the treatment of retinal tumors of LH beta-Tag murine transgenic model of retinoblastoma.
Suárez F; Jockovich ME; Hernandez E; Feuer W; Parel JM; Murray TG
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3437-40. PubMed ID: 17652710
[TBL] [Abstract][Full Text] [Related]
18. The p75 NTR neurotrophin receptor is a tumor suppressor in human and murine retinoblastoma development.
Dimaras H; Gallie BL
Int J Cancer; 2008 May; 122(9):2023-9. PubMed ID: 18196575
[TBL] [Abstract][Full Text] [Related]
19. Optical Coherence Tomography-Guided Decisions in Retinoblastoma Management.
Soliman SE; VandenHoven C; MacKeen LD; Héon E; Gallie BL
Ophthalmology; 2017 Jun; 124(6):859-872. PubMed ID: 28318638
[TBL] [Abstract][Full Text] [Related]
20. OCT-guided management of subclinical recurrent retinoblastoma.
Gaillard MC; Houghton S; Stathopoulos C; Munier FL
Ophthalmic Genet; 2018 Jun; 39(3):338-343. PubMed ID: 29424610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
